Literature DB >> 25456816

Structural basis of a point mutation that causes the genetic disease aspartylglucosaminuria.

Lufei Sui1, Damodharan Lakshminarasimhan1, Suchita Pande1, Hwai-Chen Guo2.   

Abstract

Aspartylglucosaminuria (AGU) is a lysosomal storage disease caused by a metabolic disorder of lysosomes to digest Asn-linked glycoproteins. The specific enzyme linked to AGU is a lysosomal hydrolase called glycosylasparaginase. Crystallographic studies revealed that a surface loop blocks the catalytic center of the mature hydrolase. Autoproteolysis is therefore required to remove this P loop and open up the hydrolase center. Nonetheless, AGU mutations result in misprocessing of their precursors and are deficient in hydrolyzing glycoasparagines. To understand the catalytic and structural consequences of AGU mutations, we have characterized two AGU models, one corresponding to a Finnish allele and the other found in a Canadian family. We also report a 2.1 Å resolution structure of the latter AGU model. The current crystallographic study provides a high-resolution structure of an AGU mutant. It reveals substantial conformation changes at the defective autocleavage site of the AGU mutant, which is trapped as an inactive precursor.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25456816      PMCID: PMC4271792          DOI: 10.1016/j.str.2014.09.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  32 in total

1.  Structural insights into the mechanism of intramolecular proteolysis.

Authors:  Q Xu; D Buckley; C Guan; H C Guo
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

2.  A novel exonic mutation in the aspartylglucosaminidase gene causes exon skipping.

Authors:  M B Coulter-Mackie
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

3.  Structural comparison of Ntn-hydrolases.

Authors:  C Oinonen; J Rouvinen
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

Review 4.  Protein splicing and related forms of protein autoprocessing.

Authors:  H Paulus
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

5.  BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences.

Authors:  T A Tatusova; T L Madden
Journal:  FEMS Microbiol Lett       Date:  1999-05-15       Impact factor: 2.742

6.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

7.  Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations.

Authors:  J Saarela; M Laine; C Oinonen; C von Schantz; A Jalanko; J Rouvinen; L Peltonen
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

Review 8.  Aspartylglycosaminuria: biochemistry and molecular biology.

Authors:  N N Aronson
Journal:  Biochim Biophys Acta       Date:  1999-10-08

9.  Purification and crystallization of precursors and autoprocessed enzymes of Flavobacterium glycosylasparaginase: an N-terminal nucleophile hydrolase.

Authors:  T Cui; P H Liao; C Guan; H C Guo
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-11

10.  A dual role for an aspartic acid in glycosylasparaginase autoproteolysis.

Authors:  Xiaofeng Qian; Chudi Guan; Hwai-Chen Guo
Journal:  Structure       Date:  2003-08       Impact factor: 5.006

View more
  6 in total

1.  The T99K variant of glycosylasparaginase shows a new structural mechanism of the genetic disease aspartylglucosaminuria.

Authors:  Suchita Pande; Hwai-Chen Guo
Journal:  Protein Sci       Date:  2019-04-09       Impact factor: 6.725

2.  Biochemical and structural insights into an allelic variant causing the lysosomal storage disorder - aspartylglucosaminuria.

Authors:  Suchita Pande; William Bizilj; Hwai-Chen Guo
Journal:  FEBS Lett       Date:  2018-07-23       Impact factor: 4.124

3.  Crystal structure of a mutant glycosylasparaginase shedding light on aspartylglycosaminuria-causing mechanism as well as on hydrolysis of non-chitobiose substrate.

Authors:  Suchita Pande; Damodharan Lakshminarasimhan; Hwai-Chen Guo
Journal:  Mol Genet Metab       Date:  2017-04-19       Impact factor: 4.797

Review 4.  Aspartylglycosaminuria: a review.

Authors:  Maria Arvio; Ilkka Mononen
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

5.  Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria.

Authors:  Antje Banning; Christina Gülec; Juha Rouvinen; Steven J Gray; Ritva Tikkanen
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

Review 6.  Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage.

Authors:  Tomáš Zárybnický; Anne Heikkinen; Salla M Kangas; Marika Karikoski; Guillermo Antonio Martínez-Nieto; Miia H Salo; Johanna Uusimaa; Reetta Vuolteenaho; Reetta Hinttala; Petra Sipilä; Satu Kuure
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.